Literature DB >> 29653861

Phase I Trial of Recombinant Human Nerve Growth Factor for Neurotrophic Keratitis.

Stefano Bonini1, Alessandro Lambiase2, Paolo Rama3, Isabella Filatori4, Marcello Allegretti4, Wendy Chao4, Flavio Mantelli4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29653861     DOI： 10.1016/j.ophtha.2018.03.004

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  16 in total

Review 1.  Corneal neurotization for neurotrophic keratopathy: Review of surgical techniques and outcomes.

Authors:  Catherine Y Liu; Andrea C Arteaga; Sammie E Fung; M Soledad Cortina; Ilya M Leyngold; Vinay K Aakalu
Journal:  Ocul Surf       Date:  2021-02-26       Impact factor: 5.033

2.  Role of Topical Cenegermin in Management of a Cornea Transplant in a Functionally Monocular Patient with Neurotrophic Keratitis and Facial Nerve Palsy: A Case Report.

Authors:  Augusto Pocobelli; Chiara Komaiha; Luca De Carlo; Giulio Pocobelli; Nicoletta Boni; Rossella Anna Maria Colabelli Gisoldi
Journal:  Int Med Case Rep J       Date:  2020-11-11

Review 3.  Cenegermin: A Review in Neurotrophic Keratitis.

Authors:  Emma D Deeks; Yvette N Lamb
Journal:  Drugs       Date:  2020-04       Impact factor: 9.546

Review 4.  [Corneal neurotization].

Authors:  J N Lueke; C Holtmann; K Beseoglu; G Geerling
Journal:  Ophthalmologe       Date:  2020-03       Impact factor: 1.059

5.  Update On Cenegermin Eye Drops In The Treatment Of Neurotrophic Keratitis.

Authors:  Hosam Sheha; Sean Tighe; Omar Hashem; Yasutaka Hayashida
Journal:  Clin Ophthalmol       Date:  2019-10-07

6.  Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study.

Authors:  Marta Sacchetti; Alessandro Lambiase; Doreen Schmidl; Leopold Schmetterer; Mauro Ferrari; Flavio Mantelli; Marcello Allegretti; Gerhard Garhoefer
Journal:  Br J Ophthalmol       Date:  2019-04-03       Impact factor: 4.638

7.  Long-term clinical outcome and satisfaction survey in patients with neurotrophic keratopathy after treatment with cenegermin eye drops or amniotic membrane transplantation.

Authors:  Marta Sacchetti; Chiara Komaiha; Alice Bruscolini; Giuseppe Maria Albanese; Marco Marenco; Rossella Anna Maria Colabelli Gisoldi; Augusto Pocobelli; Alessandro Lambiase
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-10-11       Impact factor: 3.117

8.  Recombinant Human Nerve Growth Factor (Cenegermin)-Driven Corneal Wound Healing Process: An Evidence-Based Analysis.

Authors:  Chiara Bonzano; Sara Olivari; Carlo Alberto Cutolo; Angelo Macrì; Daniele Sindaco; Davide Borroni; Elisabetta Bonzano; Carlo Enrico Traverso
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

9.  Functional and Structural Changes Following Corneal Neurotisation in the Management of Neurotrophic Keratopathy: UK Single Centre Series.

Authors:  Mohamed Elalfy; Sundas Maqsood; Scott Hau; Ruben Y Kannan; Charles Nduka; Samer Hamada; Raman Malhotra
Journal:  Clin Ophthalmol       Date:  2021-05-24

10.  Topical citicoline and vitamin B12 versus placebo in the treatment of diabetes-related corneal nerve damage: a randomized double-blind controlled trial.

Authors:  Paolo Fogagnolo; Ettore Melardi; Laura Tranchina; Luca Rossetti
Journal:  BMC Ophthalmol       Date:  2020-08-01       Impact factor: 2.209
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.